Works matching DE "APREMILAST"
Results: 189
Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1180170
- By:
- Publication type:
- Article
Author Correction: Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35741-0
- By:
- Publication type:
- Article
PDE4 Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis.
- Published in:
- Genes, 2024, v. 15, n. 3, p. 369, doi. 10.3390/genes15030369
- By:
- Publication type:
- Article
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v101.566
- By:
- Publication type:
- Article
Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 9, p. 1, doi. 10.2340/00015555-3846
- By:
- Publication type:
- Article
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 4, p. 514, doi. 10.2340/00015555-2360
- By:
- Publication type:
- Article
Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database.
- Published in:
- Open Access Rheumatology: Research & Reviews, 2022, v. 14, p. 123, doi. 10.2147/OARRR.S342123
- By:
- Publication type:
- Article
Apremilast for the management of moderate to severe plaque psoriasis.
- Published in:
- Expert Review of Clinical Pharmacology, 2017, v. 10, n. 4, p. 349, doi. 10.1080/17512433.2017.1293519
- By:
- Publication type:
- Article
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations.
- Published in:
- Expert Review of Clinical Immunology, 2023, v. 19, n. 5, p. 499, doi. 10.1080/1744666X.2023.2185775
- By:
- Publication type:
- Article
Enantioselective Human Serum Albumin Binding of Apremilast: Liquid Chromatographic, Fluorescence and Molecular Docking Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2168, doi. 10.3390/ijms24032168
- By:
- Publication type:
- Article
Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1276, doi. 10.3390/ijms24021276
- By:
- Publication type:
- Article
Apremilast retention rate in clinical practice: observations from an Italian multi-center study.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 10, p. 3219, doi. 10.1007/s10067-022-06255-3
- By:
- Publication type:
- Article
Improving the solubility and permeability of apremilast with cyclodextrin encapsulation for the development of local drug delivery systems.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 209, doi. 10.33320/maced.pharm.bull.2023.69.03.103
- By:
- Publication type:
- Article
Activity of apremilast in a patient with severe pemphigus vulgaris: case report.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1404185
- By:
- Publication type:
- Article
Successful treatment with apremilast for palmar, yet not plantar, plaque psoriasis in a pediatric patient.
- Published in:
- Our Dermatology Online / Nasza Dermatologia Online, 2023, v. 14, n. 2, p. 219, doi. 10.7241/ourd.20232.25
- By:
- Publication type:
- Article
Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer‐blinded comparative study.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 11, p. 1535, doi. 10.1111/ijd.17185
- By:
- Publication type:
- Article
Efficacy of apremilast in a case of resistant linear IgA bullous disease.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 5, p. e300, doi. 10.1111/ijd.16548
- By:
- Publication type:
- Article
Apremilast in combination with botulinum toxin‐A injection for recalcitrant Hailey‐Hailey disease.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 5, p. 600, doi. 10.1111/ijd.15953
- By:
- Publication type:
- Article
Apremilast: First Pediatric Approval: Apremilast: First Pediatric Approval: H. A. Blair.
- Published in:
- Pediatric Drugs, 2025, v. 27, n. 1, p. 119, doi. 10.1007/s40272-024-00668-0
- By:
- Publication type:
- Article
Zápis ze schůze výboru ČDS konané dne 12. 9. 2023.
- Published in:
- Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie, 2023, v. 98, n. 5, p. 268
- Publication type:
- Article
Zápisy.
- Published in:
- Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie, 2023, v. 98, n. 4, p. 223
- Publication type:
- Article
Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach.
- Published in:
- Journal of Chromatographic Science, 2021, v. 59, n. 10, p. 928, doi. 10.1093/chromsci/bmab016
- By:
- Publication type:
- Article
What insights can be gained from optimizing the relevant research on methotrexate monotherapy versus methotrexate and apremilast combination therapy in the treatment of palmoplantar psoriasis?
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2024, v. 90, n. 2, p. 1, doi. 10.25259/IJDVL_337_2023
- By:
- Publication type:
- Article
Darier disease responding to apremilast: Report of two cases.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2024, v. 90, n. 2, p. 1, doi. 10.25259/IJDVL_83_2023
- By:
- Publication type:
- Article
Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In‐vitro permeation and preclinical evaluation.
- Published in:
- Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22191
- By:
- Publication type:
- Article
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 433, doi. 10.3390/biomedicines11020433
- By:
- Publication type:
- Article
Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1303, doi. 10.3390/biomedicines10061303
- By:
- Publication type:
- Article
Impact of Renal Impairment on the Pharmacokinetics of Apremilast and Metabolite M12.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 469, doi. 10.1002/cpdd.256
- By:
- Publication type:
- Article
Apremilast: A Review in Oral Ulcers of Behçet's Disease.
- Published in:
- Drugs, 2020, v. 80, n. 2, p. 181, doi. 10.1007/s40265-019-01253-3
- By:
- Publication type:
- Article
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
- Published in:
- Drugs, 2017, v. 77, n. 4, p. 459, doi. 10.1007/s40265-017-0709-1
- By:
- Publication type:
- Article
Rapid and sustained response to apremilast in a patient with long-standing acrodermatitis continua of Hallopeau.
- Published in:
- Dermatology Online Journal, 2022, v. 28, n. 6, p. 1, doi. 10.5070/D328659731
- By:
- Publication type:
- Article
Comparative evaluation of efficacy and tolerability of apremilast and methotrexate in patients of moderate-to-severe palmoplantar psoriasis: A randomized, parallel, open-label clinical trial.
- Published in:
- Indian Journal of Pharmacology, 2023, v. 55, n. 6, p. 356, doi. 10.4103/ijp.ijp_190_23
- By:
- Publication type:
- Article
Apremilast induced intolerable dizziness: A rare unlisted adverse effect.
- Published in:
- Indian Journal of Drugs in Dermatology, 2023, v. 9, n. 2, p. 80, doi. 10.4103/ijdd.ijdd_12_23
- By:
- Publication type:
- Article
Evaluating the efficacy of apremilast combined with low-dose steroids versus combination of apremilast with low-dose steroids and low-dose aspirin for selected cases in the management of erythema nodusum leprosum: A pilot study.
- Published in:
- Indian Journal of Drugs in Dermatology, 2023, v. 9, n. 1, p. 13, doi. 10.4103/ijdd.ijdd_47_21
- By:
- Publication type:
- Article
Gratifying results of apremilast in unstable erythrodermic psoriasis.
- Published in:
- Indian Journal of Drugs in Dermatology, 2022, v. 8, n. 1, p. 40, doi. 10.4103/ijdd.ijdd_27_21
- Publication type:
- Article
The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials.
- Published in:
- Journal of Cosmetic Dermatology, 2023, v. 22, n. 9, p. 2553, doi. 10.1111/jocd.15903
- By:
- Publication type:
- Article
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 3, p. 395, doi. 10.3390/life14030395
- By:
- Publication type:
- Article
Apremilast Ameliorates Experimental Arthritis <italic>via</italic> Suppression of Th1 and Th17 Cells and Enhancement of CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells Differentiation.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01662
- By:
- Publication type:
- Article
Apremilast for the treatment of active psoriatic arthritis: a single-centre real-life experience.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Thermosensitive In Situ Gel of Nanosized Apremilast: Development and Assessment for Rheumatoid Arthritis Treatment.
- Published in:
- Nano Life, 2024, v. 14, n. 2, p. 1, doi. 10.1142/S1793984424500028
- By:
- Publication type:
- Article
Oral Apremilast for the Treatment of Plaque Psoriasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of Inflammatory Factors Levels and Safety in the Treatment of Psoriasis with Apremilast.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2022, v. 84, p. 232
- By:
- Publication type:
- Article
A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.
- Published in:
- Expert Review of Clinical Immunology, 2016, v. 12, n. 3, p. 237, doi. 10.1586/1744666X.2016.1134319
- By:
- Publication type:
- Article
Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland.
- Published in:
- Scandinavian Journal of Rheumatology, 2023, v. 52, n. 5, p. 549, doi. 10.1080/03009742.2022.2151109
- By:
- Publication type:
- Article
Correction.
- Published in:
- 2023
- Publication type:
- Correction Notice
Systematic review of biologic use for psoriasis in HIV-positive individuals from 2018 to 2024.
- Published in:
- Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-024-03395-1
- By:
- Publication type:
- Article
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 2, p. 215, doi. 10.1007/s00403-022-02343-1
- By:
- Publication type:
- Article
Key Advances in Oral Therapies for Psoriasis Unveiled at Winter Clinical Dermatology Conference 2025.
- Published in:
- 2025
- By:
- Publication type:
- Abstract